Understanding the impact of mitochondrial defects in cardiovascular disease: A review

Journal of Cardiac Failure

Volumn 8, Issue 5, 2002, Pages 347-361

  Marín García, José ^a   Goldenthal, Michael J ^a  

^a The Molecular Cardiology and Neuromuscular Institute   (United States)

Author keywords

Cardiovascular disease; Mitochondria

Indexed keywords

AMIODARONE; CARNITINE; CARVEDILOL; IDEBENONE; MITOCHONDRIAL DNA; MITOCHONDRIAL PROTEIN; PERHEXILINE; UBIQUINONE;

AGING; ALCOHOLIC CARDIOMYOPATHY; ANIMAL MODEL; BIOENERGY; BIOGENESIS; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; DIAGNOSTIC TEST; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG EFFECT; DRUG EFFICACY; EMBRYO CELL; GENE MUTATION; GENETIC DISORDER; HEART ARRHYTHMIA; HEART DEVELOPMENT; HEART DILATATION; HEART MITOCHONDRION; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SENESCENCE; STEM CELL; SUDDEN DEATH;

EID: 0036774412     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1054/jcaf.2002.127774     Document Type: Article

References (140)

1. Anderson S, Bankier AT, Barrell BG, De Bruijn MHL, Coulson AR, Drouin J, Eperon IC, Nierlich DP, Roe BA, Sanger F, Schreier PH, Smith AJ, Staden R, Young IG: Sequence and organization of human mitochondrial genome. Nature 1981;290:457-465
2. Attardi G, Schatz G: Biogenesis of mitochondria. Annu Rev Cell Biol 1988;4:289-333
3. Shadel GS, Clayton DA: Mitochondrial DNA maintenance in vertebrates. Annu Rev Biochem 1997;66:409-435
4. Sack MN, Harrington LS, Jonassen AK, Mjos OD, Yellon DM: Coordinate regulation of metabolic enzyme encoding genes during cardiac development and following carvedilol therapy in spontaneously hypertensive rats. Cardiovasc Drugs Ther 2000;14:31-39
5. Brown NF, Weis BC, Husti JE, Foster DW, McGarry JD: Mitochondrial carnitine palmitoyltransferase I isoform switching in the developing rat heart. J Biol Chem 1995;270:8952-8957
6. Cook GA, Edwards TL, Jansen MS, Bahouth SW, Wilcox HG, Park EA: Differential regulation of carnitine palmitoyltransferase-I gene isoforms (CPT-I alpha and CPT-I beta) in the rat heart. J Mol Cell Cardiol 2001;33:317-329
7. Razeghi P, Young ME, Alcorn JL, Michael J. Goldenthal JL, Moravec CS, Frazier OH, Taegtmeyer H: Metabolic gene expression in fetal and failing human heart. Circulation 2001;104:2923-2931
8. Van Nieuwenhoven FA, Willemsen PH, Van der Vusse GJ, Glatz JF: Co-expression in rat heart and skeletal muscle of four genes coding for proteins implicated in long-chain fatty acid uptake. Int J Biochem Cell Biol 1999;31:489-498
9. Marin-Garcia J, Ananthakrishnan R, Goldenthal MJ: Human mitochondrial function during cardiac growth and development. Mol Cell Biochem. 1998;179:21-26
10. McMillin JB, Taffet GE, Taegtmeyer H, Hudson EK, Tate CA: Mitochondrial metabolism and substrate competition in the aging Fischer rat heart. Cardiovasc Res 1993:27:2222-2228
11. Paradies G, Ruggiero FM: Age-related changes in the activity of the pyruvate carrier and in the lipid composition in rat-heart mitochondria. Biochim Biophys Acta 1990;1016:207-221
12. Lopez Jimenez JA, Bordoni A, Lorenzini A, Rossi CA, Biagi PL, Hrelia S: Linoleic acid metabolism in primary cultures of adult rat cardiomyocytes is impaired by aging. Biochem Biophys Res Commun 1997;237:142-145
13. Costell M, O'Connor JE, Grisolia S: Age-dependent decrease of carnitine content in muscle of mice and humans. Biochem Biophys Res Commun 1989;161:1135-1143
14. Linnane AW, Marzuki S, Ozawa T, Tanaka M: Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases. Lancet 1989;1:642-645
15. Hattori K, Tanaka M, Sugiyama S, Obayashi T, Ito T, Satake T, Hanaki Y, Asai J, Nagano M, Ozawa T: Age-dependent increase in deleted mitochondrial DNA in the human heart: Possible contributory factor in presbycardia. Am Heart J 1991;121:1735-1742
16. Muller-Hocker J: Cytochrome-c-oxidase deficient cardiomyocytes in the human heart - An age-related phenomenon. A histochemical ultracytochemical study. Am J Pathol 1989;134:1167-1173
17. Miro O, Casademont J, Casals E, Perea M, Urbano-Marquez A, Rustin P, Cardellach F: Aging is associated with increased lipid peroxidation in human hearts, but not with mitochondrial respiratory chain enzyme defects. Cardiovasc Res 2000;47:624-631
18. Marin-Garcia J, Goldenthal JM, Moe GW: Mitochondrial pathology in cardiac failure. Cardiovasc Res 2001;49:17-26
19. Rustin P, Lebidois J, Chretien D, Bourgeron T, Piechaud JF, Rotig A, Munnich A, Sidi D: Endomyocardial biopsies for early detection of mitochondrial disorders in hypertrophic cardiomyopathies. J Pediatr 1994;124:224-228
20. Buchwald A, Till H, Unterberg C, Oberschmidt R, Figulla HR, Wiegand V: Alterations of the mitochondrial respiratory chain in human dilated cardiomyopathy. Eur Heart J 1990;11:509-516
21. Marin-Garcia J, Ananthakrishnan R, Goldenthal MJ, Filiano JJ, Perez-Atayde A: Cardiac mitochondrial dysfunction and DNA depletion in children with hypertrophic cardiomyopathy. J Inherit Metab Dis 1997;20:674-680
22. Ile mutation in fatal cardiomyopathy. Biochem Biophys Res Commun 1992;186:47-53
23. LEU(UUR) gene associated with maternally inherited cardiomyopathy. Hum Mutat 1994;3:37-43
24. Santorelli FM, Mak S-C, Vazquez-Acevedo M, Gonzalez-Astiazaran A, Ridaura-Sanz C, Gonzalez-Halphen D, DiMauro S: A novel mtDNA point mutation associated with mitochondrial encephalocardiomyopathy. Biochem Biophys Res Commun 1995;216:835-840
25. Lys gene (G8363). Am J Hum Genet 1996;58:933-939
26. Gly gene. Am J Hum Genet 1994;55:437-446
27. Leu. Lancet 1991;338:143-147
28. Casali C, Santorelli FM, D'Amati G, Bernucci P, DeBiase L, DiMauro S: A novel mtDNA point mutation in maternally inherited cardiomyopathy. Biochem Biophys Res Commun 1995;213:588-593
29. Schon EA, Bonilla E, DiMauro S: Mitochondrial DNA mutations and pathogenesis. J Bioenerg Biomembr 1997;29:131-149
30. Santorelli FM, Tanji K, Manta P, Casali C, Krishna S, Hays AP, Mancini DM, DiMauro S, Hirano M: Maternally inherited cardiomyopathy: An atypical presentation of the mtDNA 12S rRNA gene A1555G mutation. Am J Hum Genet 1999;64:295-300
31. Arbustini E, Diegoli M, Fasani R, Grasso M, Morbini P, Banchieri N, Bellini O, Dal Bello B, Pilotto A, Magrini G, Campana C, Fortina P, Gavazzi A, Narula J, Vigano M: Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy. Am J Pathol 1998;153:1501-1510
32. Li YY, Maisch B, Rose ML, Hengstenberg C: Point mutations in mitochondrial DNA of patients with dilated cardiomyopathy. J Mol Cell Cardiol 1997;29:2699-2709
33. Marin-Garcia J, Goldenthal MJ, Ananthakrishnan R, Pierpont ME: The complete sequence of mtDNA genes in idiopathic dilated cardiomyopathy shows novel missense and tRNA mutations. J Card Fail 2000;6:321-329
34. Shoffner JM, Wallace DC: Heart disease and mitochondrial DNA mutations. Heart Dis Stroke 1992;1:235-241
35. Pastores GM, Santorelli FM, Shanske S, Gelb BD, Fyfe B, Wolfe D, Willner JP: Leigh syndrome and hypertrophic cardiomyopathy in an infant with a mitochondrial point mutation (T8993G). Am J Med Genet 1994;50:265-271
36. Anan R, Nakagawa M, Miyata M, Higuchi I, Nakao S, Suehara M, Osame M, Tanaka H: Cardiac involvement in mitochondrial diseases: A study of 17 patients with mitochondrial DNA defects. Circulation 1995;91:955-961
37. Graf WD, Marin-Garcia J, Gao HG, Pizzo S, Naviaux RK, Markusic D, Barshop BA, Courchesne E, Haas RH: Autism associated with the mitochondrial DNA G8363A transfer RNA(Lys) mutation. J Child Neurol 2000;15:357-361
38. Matthews PM, Marchington DR, Squier M, Land J, Brown R, Brown GK: Molecular genetic characterization of an X-linked form of Leigh's syndrome. Ann Neurol 1993;33:652-655
39. Bourgeron T, Rustin P, Chretien D, Birch-Machin M, Bourgeois M, Viegas-Pequignot E, Munnich A, Rotig A: Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat Genet 1995;11:144-149
40. Filiano JJ, Goldenthal MJ, Mamourian AC, Hall CC, Marin-Garcia J: Mitochondrial DNA depletion in Leigh syndrome. Pediatr Neurol. 2002;26:239-242
41. Holt IJ, Harding AE, Morgan-Hughes JA: Deletions of mtDNA in patients with mitochondrial myopathies. Nature 1988;331:717-719
42. Zeviani M, Moraes CT, DiMauro S, Nakase H, Bonilla E, Schon EA, Rowland LP: Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology 1988;38:1339-1346
43. Bohlega S, Tanji K, Santorelli FM, Hirano M, al-Jishi A, DiMauro S: Multiple mitochondrial DNA deletions associated with autosomal recessive ophthalmoplegia and severe cardiomyopathy. Neurology 1996;46:1329-1334
44. Suomalainen A, Paetau A, Leinonen H, Majander A, Peltonen L, Somer H: Inherited idiopathic dilated cardiomyopathy with multiple deletions of mitochondrial DNA. Lancet 1992;340:1319-1320
45. Marin-Garcia J, Goldenthal MJ, Ananthakrishnan R, Pierpont ME, Fricker FJ, Lipshultz S, Perez-Atayde A: Specific mitochondrial DNA deletions in idiopathic dilated cardiomyopathy. Cardiovasc Res 1996;31:306-314
46. Simonetti S, Chen X, DiMauro S, Schon E: Accumulation of deletions in human mitochondrial DNA during normal aging: Analysis by quantitative PCR. Biochim Biophys Acta 1992;1180:113-122
47. Marin-Garcia J, Ananthakrishnan R, Goldenthal MJ, Pierpont ME: Biochemical and molecular basis for mitochondrial cardiomyopathy in neonates and children. J Inherit Metab Dis 2000;23:625-633
48. Lewis W, Dalakas MC: Mitochondrial toxicity of antiviral drugs. Nature Med 1995;1:417-422
49. Herskowitz A, Willoughby SB, Baughman KL, Schulman SP, Bartlett JD: Cardiomyopathy associated with antiretroviral therapy in patients with HIV infection: A report of 6 cases. Ann Intern Med 1992;116:311-313
50. Huizing M, Iacobazzi V, Ijlst L, Savelkoul P, Ruitenbeek W, van den Heuvel L, Indiveri C, Smeitink J, Trijbels F, Wanders R, Palmieri F: Cloning of the human carnitineacylcarnitine carrier cDNA and identification of the molecular defect in a patient. Am J Hum Genet 1997;61:1239-1245
51. Campuzano V, Montermini L, Molto MD, Pianese L, Cossee M, Cavalcanti F, Monros E, Rodius F, Duclos F, Monticelli A, Zara F, Canizares J, Koutnikova H, Bidichandani SI, Gellera C, Brice A, Trouillas P, De Michele G, Filla A, De Frutos R, Palau F, Patel PI, Di Donato S, Mandel J-L, Cocozza S, Koenig M, Pandolfo M: Friedreich's ataxia: Autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 1996;271:1423-1427
52. Papadopoulou LC, Sue CM, Davidson MM, Tanji K, Nishino I, Sadlock JE, Krishna S, Walker W, Selby J, Glerum DM, Coster RV, Lyon G, Scalais E, Lebel R, Kaplan P, Shanske S, De Vivo DC, Bonilla E, Hirano M, DiMauro S, Schon EA: Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene. Nat Genet 1999;23:333-337
53. Sue CM, Karadimas C, Checcarelli N, Tanji K, Papadopoulou LC, Pallotti F, Guo FL, Shanske S, Hirano M, De Vivo DC, Van Coster R, Kaplan P, Bonilla E, DiMauro S: Differential features of patients with mutations in two COX assembly genes, SURF-1 and SCO2. Ann Neurol 2000;47:589-595
54. Kelly DP, Strauss AW: Inherited cardiomyopathies. N Eng J Med 1994;330:913-919
55. Strauss AW, Powell CK, Hale DE, Anderson MM, Ahuja A, Brackett JC, Sims HF: Molecular basis of human mitochondrial very-long-chain acyl-CoA dehydrogenase deficiency causing cardiomyopathy and sudden death in childhood. Proc Natl Acad Sci U S A 1995;92:10496-10500
56. Rocchiccioli F, Wanders RJ, Aubourg P, Vianey-Liaud C, Ijlst L, Fabre M, Cartier N, Bougneres PF: Deficiency of long-chain 3-hydroxyacyl-CoA dehydrogenase: A cause of lethal myopathy and cardiomyopathy in early childhood. Pediatr Res 1990;28:657-662
57. Tein I, Haslam RH, Rhead WJ, Bennett MJ, Becker LE, Vockley J: Short-chain acyl-CoA dehydrogenase deficiency: A cause of ophthalmoplegia and multicore myopathy. Neurology 1999;52:366-372
58. Stanley CA, Treem WR, Hale DE, Coates PM: A genetic defect in carnitine transport causing primary carnitine deficiency. Prog Clin Biol Res 1990;321:457-464
59. Brackett JC, Sims HF, Rinaldo P, Shapiro S, Powell CK, Bennett MJ, Strauss AW: Two subunit donor splice site mutations cause human trifunctional protein deficiency. J Clin Invest 1995;95:2076-2082
60. D'Adamo P, Fassone L, Gedeon A, Janssen EA, Bione S, Bolhuis PA, Barth PG, Wilson M, Haan E, Orstavik KH, Patton MA, Green AJ, Zammarchi E, Donati MA, Toniolo D: The X-linked gene G4.5 is responsible for different infantile dilated cardiomyopathies. Am J Hum Genet 1997;61:862-867
61. Neuwald AF: Barth syndrome may be due to an acyltransferase deficiency. Curr Biol 1997;7:R465-R466
62. Vreken P, Valianpour F, Nijtmans LG, Grivell LA, Plecko B, Wanders RJ, Barth PG: Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome. Biochem Biophys Res Commun 2000;279:378-382
63. Fananapazir L, Dalakas MC, Cyran F, Cohn G, Epstein ND: Missense mutations in the beta-myosin heavy-chain gene cause central core disease in hypertrophic cardiomyopathy. Proc Natl Acad Sci U S A 1993;90:3993-3997
64. Thompson CH, Kemp GJ, Taylor DJ, Conway M, Rajagopalan B, O'Donoghue A, Styles P, McKenna WJ, Radda GK: Abnormal skeletal muscle bioenergetics in familial hypertrophic cardiomyopathy. Heart 1997:78:177-181
65. Milner DJ, Mavroidis M, Weisleder N, Capetanaki Y: Desmin cytoskeleton linked to muscle mitochondrial distribution and respiratory function. J Cell Biol 2000;150:1283-1298
66. Bonnet D, Martin D, Pascale De Lonlay, Villain E, Jouvet P, Rabier D, Brivet M, Saudubray JM: Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children. Circulation 1999;100:2248-2253
67. Corr PB, Creer MH,Yamada KA, Saffitz JE, Sobel BE: Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation. J Clin Invest 1989;83:927-936
68. Tripp ME: Developmental cardiac metabolism in health and disease. Pediatr Cardiol 1989;10:150-158
69. Barger PM. Kelly DP: Fatty acid utilization in the hypertrophied and failing heart: Molecular regulatory mechanisms. Am J Med Sci 1999;318;36-42
70. Sack MN. Rader TA, Park S, Bastin J, McCune SA, Kelly DP: Fatty acid oxidation gene expression is downregulated in the failing heart. Circulation 1996;94:2837-2842
71. Kelly DP, Hale DE, Rutledge SL, Ogden ML, Whelan AJ, Zhang Z, Strauss AW: Molecular basis of inherited medium-chain acyl-CoA dehydrogenase deficiency causing sudden child death. J Inherit Metab Dis 1992;15:171-180
72. Marzo I, Brenner C, Zamzami N, Susin SA, Beutner G, Brdiczka D, Remy R, Xie ZH, Reed JC, Kroemer G: The permeability transition pore complex: A target for apoptosis regulation by caspases and Bcl-2 related proteins. J Exp Med 1998 187;1261-1271
73. Marzo I, Brenner C, Zamzami N, Jurgensmeier JM, Susin SA, Vieira HL, Prevost MC, Xie Z, Matsuyama S, Reed JC, Kroemer G: Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science 1998;281:2027-2031
74. Lemasters JJ, Nieminen AL, Qian T, Trost LC, Elmore SP, Nishimura Y, Crowe RA, Cascio WE, Bradham CA, Brenner DA, Herman B: The mitochondrial permeability transition in cell death: A common mechanism in necrosis, apoptosis and autophagy. Biochim Biophys Acta 1998;1366:177-196
75. Schinder AF, Olson EC, Spitzer NC, Montal M: Mitochondrial dysfunction is a primary event in glutamate neurotoxicity. J NeuroSci 1996;16:6125-6133
76. Schulze-Osthoff K, Bakker AC, Vanhaesebroeck B, Beyaert R, Jacob WA, Fiers W: Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. J Biol Chem 1992;267:5317-5323
77. Sanchez-Alcazar JA, Schneider E, Martinez MA, Carmona P, Hernandez-Munoz I, Siles E, De La Torre P, Ruiz-Cabello J, Garcia I, Solis-Herruzo JA: TNF-α increases the steady-state reduction of cytochrome b of the mitochondrial respiratory chain in metabolically inhibited L929 cells. J Biol Chem 2000;275:13353-13361
78. Zell R, Geck P, Werdan K, Boekstegers P: TNF-α and IL-1α inhibit both pyruvate dehydrogenase activity and mitochondrial function in cardiomyocytes: Evidence for primary impairment of mitochondrial function. Mol Cell Biochem 1997;177:61-67
79. Li YY, Chen D, Watkins SC, Feldman AM: Mitochondrial abnormalities in tumor necrosis factor-alpha-induced heart failure are associated with impaired DNA repair activity. Circulation 2001;104:2492-2497
80. Abdel-aleem S, el-Merzabani MM, Sayed-Ahmed M, Taylor DA, Lowe JE: Acute and chronic effects of adriamycin on fatty acid oxidation in isolated cardiac myocytes. J Mol Cell Cardiol 1997;29:789-797
81. Serrano J, Palmeira CM, Kuehl DW, Wallace KB: Cardioselective and cumulative oxidation of mitochondrial DNA following subchronic doxorubicin administration. Biochim Biophys Acta 1999;1411:201-205
82. Zhou S, Heller LJ, Wallace KB: Interference with calcium-dependent mitochondrial bioenergetics in cardiac myocytes isolated from doxorubicin-treated rats. Toxicol Appl Pharmacol 2001;175:60-67
83. Solem LE, Henry TR, Wallace KB: Disruption of mitochondrial calcium homeostasis following chronic doxorubicin administration. Toxicol Appl Pharmacol 1994;129:214-222
84. Adachi K, Fujiura Y, Mayumi F, Nozuhara A, Sugiu Y, Sakanashi T, Hidaka T, Toshima H: A deletion of mitochondrial DNA in murine doxorubicin-induced cardiotoxicity. Biochem Biophys Res Commun 1993;195:945-951
85. Yen HC, Oberley TD, Vichitbandha S, Ho YS, St Clair DK: The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice. J Clin Invest 1996;98:1253-1260
86. Shneyvays V, Mamedova L, Zinman T, Jacobson K, Shainberg A: Activation of A(3)adenosine receptor protects against doxorubicin-induced cardiotoxicity. J Mol Cell Cardiol 2001;33:1249-1261
87. Sayed-Ahmed MM, Salman TM, Gaballah HE, Abou El-Naga SA, Nicolai R, Calvani M: Propionyl-L-carnitine as protector against adriamycin-induced cardiomyopathy. Pharmacol Res 2001;43:513-520
88. Wang GW, Klein JB, Kang YJ: Metallothionein inhibits doxorubicin-induced mitochondrial cytochrome c release and caspase-3 activation in cardiomyocytes. J Pharmacol Exp Ther 2001;298:461-468
89. Schulze K, Schultheiss HP: The role of the ADP/ATP carrier in the pathogenesis of viral heart disease. Eur Heart J 1995;16(suppl O):64-67
90. Fuchs CS, Stampfer MJ, Colditz GA, Giovannucci EL, Manson JE, Kawachi I, Hunter DJ, Hankinson SE, Hennekens CH, Rosner B: Alcohol consumption and mortality among women. N Engl J Med 1995;332:1245-1250
91. Marin-Garcia J, Ananthakrishnan R, Goldenthal MJ: Heart mitochondria response to alcohol is different than brain and liver. Alcohol Clin Exp Res 1995;19:1463-1466
92. Siddiq T, Salisbury JR, Richardson PJ, Preedy VR: Synthesis of ventricular mitochondrial proteins in vivo: Effect of acute ethanol toxicity. Alcohol Clin Exp Res 1993;17:894-899
93. Beckemeier ME, Bora PS: Fatty acid ethyl esters: Potentially toxic products of myocardial ethanol metabolism. J Mol Cell Cardiol 1998;30:2487-2494
94. Schoppet M, Maisch B: Alcohol and the heart. Herz 2001;26:345-352
95. Graham BH, Waymire KG, Cottrell B, Trounce IA, MacGregor GR, Wallace DC: A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator. Nat Genet 1997;16:226-234
96. Lebovitz RM, Zhang H, Vogel H, Cartwright J Jr, Dionne L, Lu N, Huang S, Matzuk MM: Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc Natl Acad Sci U S A 1996;93:9782-9787
97. Li Y, Huang TT, Carlson EJ, Melov S, Ursell PC, Olson JL, Noble LJ, Yoshimura MP, Berger C, Chan PH, Wallace DC, Epstein CJ: Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet 1995;11:376-381
98. Djouadi F, Brandt JM, Weinheimer CJ, Leone TC, Gonzalez FJ, Kelly DP: The role of the peroxisome proliferator-activated receptor alpha (PPAR α) in control of cardiac lipid metabolism. Prostaglandins Leukot Essent Fatty Acids 1999;60:339-343
99. Ibdah JA, Paul H, Zhao Y, Binford S, Salleng K, Cline M, Matern D, Bennett MJ, Rinaldo P, Strauss AW: Lack of mitochondrial trifunctional protein in mice causes neonatal hypoglycemia and sudden death. J Clin Invest 2001;107:1403-1409
100. Wang J, Wilhelmsson H, Graff C, Li H, Oldfors A, Rustin P, Bruning JC, Kahn CR, Clayton DA, Barsh GS, Thoren P, Larsson NG: Dilated cardiomyopathy and atrioventricular conduction blocks induced by heart-specific inactivation of mitochondrial DNA gene expression. Nat Genet 1999;21:133-137
101. Puccio H, Simon D, Cossee M, Criqui-Filipe P, Tiziano F, Melki J, Hindelang C, Matyas R, Rustin P, Koenig M: Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat Genet 2001;27:181-186
102. Finck BN, Lehman JJ, Leone TC, Welch MJ, Bennett MJ, Kovacs A, Han X, Gross RW, Kozak R, Lopaschuk GD, Kelly DP: The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J Clin Invest 2002;109:121-130
103. Lehman JJ, Barger PM, Kovacs A, Saffitz JE, Medeiros DM, Kelly DP: Peroxisome proliferator-activated receptor gamma coactivator-I promotes cardiac mitochondrial biogenesis. J Clin Invest 2000;106:847-856
104. Melov S, Schneider JA, Day BJ, Hinerfeld D, Coskun P, Mirra SS, Crapo JD, Wallace DC: A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase. Nat Genet 1998;18:159-163
105. Kehat I, Kenyagin-Karsenti D, Snir M, Segev H, Amit M, Gepstein A, Livne E, Binah O, Itskovitz-Eldor J, Gepstein L: Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 2001;108:407-414
106. Doevendans PA, Kubalak SW, An RH, Becker DK, Chien KR, Kass RS: Differentiation of cardiomyocytes in floating embryoid bodies is comparable to fetal cardiomyocytes. J Mol Cell Cardiol 2000;32:839-851
107. Doetschman T, Shull M, Kier A, Coffin JD: Embryonic stem cell model systems for vascular morphogenesis and cardiac disorders. Hypertension 1993;22:618-629
108. Muller M, Fleischmann BK, Selbert S, Ji GJ, Endl E, Middeler G, Muller OJ, Schlenke P, Frese S, Wobus AM, Hescheler J, Katus HA, Franz WM: Selection of ventricular-like cardiomyocytes from ES cells in vitro. FASEB J 2000;14:2540-2548
109. Wobus AM, Kaomei G, Shan J, Wellner MC, Rohwedel J, Ji Guanju, Fleischmann B, Katus HA, Hescheler J, Franz WM: Retinoic acid accelerates embryonic stem cell-derived cardiac differentiation and enhances development of ventricular cardiomyocytes. J Mol Cell Cardiol 1997;29:1525-1539
110. Sauer H, Rahimi G, Hescheler J, Wartenberg M: Role of reactive oxygen species and phosphatidylinositol 3-kinase in cardiomyocyte differentiation of embryonic stem cells. FEBS Lett 2000;476:218-223
111. Bremer S, Worth AP, Paparella M, Bigot K, Kolossov E, Fleischmann BK, Hescheler J, Balls M: Establishment of an in vitro reporter gene assay for developmental cardiac toxicity. Toxicol In Vitro 2001;15:215-223
112. Sligh JE, Levy SE, Waymire KG, Allard P, Dillehay DL, Nusinowitz S, Heckenlively JR, MacGregor GR, Wallace DC: Maternal germ-line transmission of mutant mtDNAs from embryonic stem cell-derived chimeric mice. Proc Natl Acad Sci U S A 2000;97:14461-14466
113. Zullo SJ: Gene therapy of mitochondrial DNA mutations: A brief, biased history of allotopic expression in mammalian cells. Semin Neurol 2001;21:327-335
114. Marin-Garcia J, Ananthakrishnan R, Goldenthal MJ, Filiano JJ, Perez-Atayde A: Mitochondrial dysfunction in skeletal muscle of children with cardiomyopathy. Pediatrics 1999;103:456-459
115. Chomyn A, Meola G, Bresolin N, Lai ST, Scarlato G, Attardi G: In vitro genetic transfer of protein synthesis and respiration defects to mitochondrial DNA-less cells with myopathy patient mitochondria. Mol Cell Biol 1991;11:2236-2244
116. Saudubray JM, Martin D, de Lonlay P, Touati G, Poggi-Travert F, Bonnet D, Jouvet P, Boutron M, Slama A, Vianey-Saban C, Bonnefont JP, Rabier D, Kamoun P, Brivet M: Recognition and management of fatty acid oxidation defects: A series of 107 patients. J Inherit Metab Dis 1999;22:488-502
117. Shoffner JM, Wallace DC: Oxidative phosphorylation diseases and mito-chondrial DNA mutations: Diagnosis and treatment. Annu Rev Nutr 1994;14:535-568
118. Langsjuen P, Vadhanavikit S, Folkers K: Response of patients in classes III and IV of cardiomyopathy to therapy in a blind and cross-over trial with coenzyme Q10. Proc Natl Acad Sci U S A 1985;82:4240-4244
119. Rustin P, von Kleist-Retzow JC, Chantrel-Groussard K, Sidi D, Munnich A, Rotig A: Effect of idebenone on cardiomyopathy in Friedreich's ataxia: A preliminary study. Lancet 1999;354:477-479
120. Lerman-Sagie T, Rustin P, Lev D, Yanoov M, Leshinsky-Silver E, Sagie A, Ben-Gal T, Munnich A: Dramatic improvement in mitochondrial cardiomyopathy following treatment with idebenone. J Inherit Metab Dis 2001;24:28-34
121. Bonnefont JP, Demaugre F, Prip-Buus C, Saudubray JM, Brivet M, Abadi N, Thuillier L: Carnitine palmitoyltransferase deficiencies. Mol Genet Metab 1999;68:424-440
122. Brown-Harrison MC, Nada MA, Sprecher H, Vianey-Saban C, Farquhar J Jr, Gilladoga AC, Roe CR: Very long chain acyl-CoA dehydrogenase deficiency: Successful treatment of acute cardiomyopathy. Biochem Mol Med 1996;58:59-65
123. Pierpont ME, Breningstall GN, Stanley CA, Singh A: Familial carnitine transporter defect: A treatable cause of cardiomyopathy in children. Am Heart J 2000;139:S96-S106
124. Pollitt RJ: Disorders of mitochondrial long-chain fatty acid oxidation. J Inherit Metab Dis 1995;18:473-490
125. Wallhaus TR, Taylor M, DeGrado TR, Russell DC, Stanko P, Nickles RJ, Stone CK: Myocardial free fatty acid and glucose use after carvedilol treatment in patients with congestive heart failure. Circulation 2001;103:2441-2446
126. Heerdt PM, Schlame M, Jehle R, Barbone A, Burkhoff D, Blanck TJ: Disease-specific remodeling of cardiac mitochondria after a left ventricular assist device. Ann Thorac Surg 2002;73:1216-1221
127. Mital S, Loke KE, Addonizio LJ, Oz MC, Hintze TH: Left ventricular assist device implantation augments nitric oxide dependent control of mitochondrial respiration in failing human hearts. J Am Coll Cardiol 2000;36:1897-1902
128. Lee SH, Doliba N, Osbakken M, Oz M, Mancini D: Improvement of myocardial mitochondrial function after hemodynamic support with left ventricular assist devices in patients with heart failure. J Thorac Cardiovasc Surg 1998;116:344-349
129. Kawarai T, Kawakami H, Kozuka K, Izumi Y, Matsuyama Z, Watanabe C, Kohriyama T, Nakamura S: A new mitochondrial DNA mutation associated with mitochondrial myopathy: tRNA(Leu)(UUR) 3254C-to-G. Neurology 1997;49:598-600
130. Grasso M, Diegoli M, Brega A, Campana C, Tavazzi L, Arbustini E: The mitochondrial DNA mutation T12297C affects a highly conserved nucleotide of tRNA (Leu (CUN)) and is associated with dilated cardiomyopafhy. Eur J Hum Genet 2001;9:311-315
131. Tanaka M, Ino H, Ohno K, Hattori K, Sato W, Ozawa T, Itoyama S: Mitochondrial mutation in fatal infantile cardiomyopathy. Lancet 1990;336:1452
132. Merante F, Myint T, Tein I, Benson L, Robinson BH: An additional mitochondrial tRNA (Ile) point mutation (A-to-G at nucleotide 4295) causing hypertrophic cardiomyopathy. Hum Mutat 1996;8:216-222
133. Corona P, Lamantea E, Greco M, Carrara F, Agostino A, Guidetti D, Dotti MT, Mariotti C, Zeviani M: Novel heteroplasmic mtDNA mutation in a family with heterogeneous clinical presentations. Ann Neurol 2002;51:118-122
134. Akita Y, Koga Y, Iwanaga R, Wada N, Tsubone J, Fukuda S, Nakamura Y, Kato H: Fatal hypertrophic cardiomyopathy associated with an A8296G mutation in the mitochondrial tRNA(Lys) gene. Hum Mutat 2000;15:382
135. Terasaki F, Tanaka M, Kawamura K, Kanzaki Y, Okabe M, Hayashi T, Shimomura H, Ito T, Suwa M, Gong JS, Zhang J, Kitaura Y: A case of cardiomyopathy showing progression from the hypertrophic to the dilated form: Association of Mt 8348A→G mutation in the mitochondrial tRNA (Lys) gene with severe ultrastructural alterations of mitochondria in cardiomyocytes. Jpn Circ J 2001;65:691-694
136. Karadimas C, Tanji K, Geremek M, Chronopoulou P, Vu T, Krishna S, Sue CM, Shanske S, Bonilla E, DiMauro S, Lipson M, Bachman R: A5814G mutation in mitochondrial DNA can cause mitochondrial myopathy and cardiomyopathy. J Child Neurol 2001;16:531-533
137. Hsieh RH, Li JY, Pang CY, Wei YH: A novel mutation in the mitochondrial 16S rRNA gene in a patient with MELAS syndrome, diabetes mellitus, hyperthyroidism and cardiomyopathy. J Biomed Sci 2001;8:328-335
138. Obayashi T, Hattori K, Sugiyama S, Tanaka M, Tanaka T, Itoyama S, Deguchi H, Kawamura K, Koga Y, Toshima H, Takeda N, Nagano M, Ito T, Ozawa T: Point mutations in mitochondrial DNA in patients with hypertrophic cardiomyopathy. Am Heart J 1992;124:1263-1269
139. Marin-Garcia J, Ananthakrishnan R, Gonzalvo A, Goldenthal MJ: Novel mutations in mitochondrial cytochrome b in a case of fatal post-partum cardiomyopathy. J Inher Metab Dis 1995;18:77-78
140. Andreu AL, Checcarelli N, Iwata S, Shanske S, DiMauro S: A missense mutation in the mitochondrial cytochrome b gene in a revisited case with histiocytoid cardiomyopathy. Pediatr Res 2000;48:311-314.